Leadership Overview
Charles River has 9 executives leading key functions including strategy, operations, finance, technology, people, and communications.
Driven by innovation, Charles River accelerates the development of critical drugs, chemicals, and medical devices, enabling maximum speed and confidence on the drive to market through an expansive end-to-end portfolio and proven scientific guidance.
Driven by innovation, Charles River accelerates the development of critical drugs, chemicals, and medical devices, enabling maximum speed and confidence on the drive to market through an expansive end-to-end portfolio and proven scientific guidance.
Leadership Roles at Charles River
Birgit Girshick - Chief Executive Officer
Birgit Girshick, the Chief Executive Officer at Charles River, directs the overarching strategy and operational execution for the organization. This leadership role involves guiding the company's mission to accelerate drug, chemical, and medical device development for patients worldwide. Girshick ensures the integrated approach across the expansive end-to-end portfolio maximizes speed and confidence in bringing vital solutions to market. Overseeing global capacity and scientific advisory functions, Birgit Girshick drives the company's commitment to supporting clients from basic research through manufacturing and commercialization. The Chief Executive Officer's focus remains on fostering innovation and maintaining the highest standards of scientific and regulatory guidance, directly impacting market access and patient outcomes.
Glenn Coleman - Chief Financial Officer
Glenn Coleman, the Chief Financial Officer at Charles River, oversees all financial operations and strategic fiscal planning. This executive function is critical for supporting the company's mission to accelerate the development of drugs, chemicals, and medical devices. Coleman manages financial resources to ensure the expansive end-to-end portfolio can operate with maximum efficiency and speed. By directing investment strategies and financial controls, Glenn Coleman enables Charles River to maintain confidence in its drive to market. The Chief Financial Officer's oversight extends to ensuring robust financial health across all client support functions, from basic research to commercialization, underpinning the company's integrated approach and global capacity.
Peter Y. - Divisional Chief Financial Officer & Vice President, Finance
Peter Y., the Divisional Chief Financial Officer & Vice President, Finance at Charles River, manages financial strategy and operations for specific business divisions. This executive function is integral to supporting the company's broad mission of accelerating drug, chemical, and medical device development. Peter Y. ensures financial resources are allocated effectively to support the end-to-end portfolio, enhancing speed and confidence in market delivery. By providing detailed financial analysis and oversight, this leadership role contributes to the strategic decision-making process across various operational segments. The Divisional Chief Financial Officer's expertise is crucial for maintaining financial discipline and driving profitable growth within their designated areas of responsibility.
Stacey Pauze - Chief of Staff
Stacey Pauze, the Chief of Staff at Charles River, provides critical operational support and strategic alignment across executive functions. This role involves facilitating communication and driving key initiatives that enhance the company's ability to accelerate drug, chemical, and medical device development. Pauze ensures seamless execution of the company's end-to-end portfolio, supporting clients from discovery through commercialization. By managing cross-functional projects and optimizing internal processes, Stacey Pauze contributes directly to the organization's drive for market speed and confidence. The Chief of Staff's efforts are vital in maintaining operational efficiency and supporting the leadership team's strategic objectives, ensuring Charles River's integrated approach delivers maximum impact.
Matthew Hewitt - Vice President, Chief Technology Officer Manufacturing Business Division
Matthew Hewitt, the Vice President, Chief Technology Officer Manufacturing Business Division at Charles River, architects and directs the technological infrastructure supporting manufacturing operations. This critical role ensures the seamless integration of advanced technologies to accelerate the production of drugs, chemicals, and medical devices. Hewitt drives innovation in manufacturing processes, enhancing the efficiency and reliability of the company's end-to-end portfolio. By focusing on technological advancements, Matthew Hewitt supports Charles River's commitment to delivering solutions with maximum speed and confidence to clients. The Chief Technology Officer's leadership ensures that manufacturing capabilities align with the company's scientific and regulatory advisory strengths, facilitating market readiness.
Mark Mintz - Executive VP & Global Chief Information Officer, Shared Services
Mark Mintz, the Executive VP & Global Chief Information Officer, Shared Services at Charles River, leads the strategic development and implementation of global information technology infrastructure. This role is fundamental to supporting the company's mission of accelerating drug, chemical, and medical device development by ensuring robust and secure IT systems. Mintz oversees the shared services IT functions, optimizing technology solutions that enhance operational efficiency and data integrity across the end-to-end portfolio. By driving digital transformation initiatives, Mark Mintz ensures Charles River maintains a competitive edge and confidence in its technological capabilities. The Global Chief Information Officer's vision is key to enabling seamless client support and advancing the company's integrated approach.
Victoria Creamer - Chief People Officer
Victoria Creamer, the Chief People Officer at Charles River, directs human capital strategy to support the company's mission of accelerating drug, chemical, and medical device development. This executive role focuses on cultivating a talented and engaged workforce essential for driving innovation and operational excellence. Creamer oversees talent acquisition, development, and retention programs, ensuring Charles River has the expertise needed to support its expansive end-to-end portfolio. By fostering a culture of collaboration and continuous learning, Victoria Creamer enhances the company's ability to deliver solutions with speed and confidence. The Chief People Officer's leadership is vital in aligning people strategies with business objectives, underpinning the company's scientific and regulatory advisory strengths.
Amy Cianciaruso - Corporate Senior Vice President, Chief Communications Officer
Amy Cianciaruso, the Corporate Senior Vice President, Chief Communications Officer at Charles River, leads strategic communication efforts to articulate the company's mission and impact. This role is crucial for conveying Charles River's commitment to accelerating drug, chemical, and medical device development to all stakeholders. Cianciaruso oversees corporate branding, public relations, and internal communications, ensuring consistent messaging that reinforces the company's end-to-end capabilities and scientific expertise. By managing external and internal narratives, Amy Cianciaruso enhances Charles River's reputation and builds confidence in its market position. The Chief Communications Officer's strategic guidance ensures that the company's value proposition is clearly communicated, supporting its drive to market.
Ameer Badi - Doctror
Ameer Badi, the Doctror at Charles River, contributes specialized medical and scientific expertise to support the company's core mission. This role is integral to advancing the development of drugs, chemicals, and medical devices by providing critical insights and guidance. Badi's contributions enhance the scientific rigor and advisory capabilities that underpin Charles River's end-to-end portfolio. By applying deep medical knowledge, Ameer Badi supports the acceleration of research and development efforts, ensuring clients receive expert consultation. The Doctror's involvement is key to maintaining the high standards of scientific and regulatory advice that Charles River offers, fostering confidence in the drive to market.
Explore Leadership Teams in Business Services
Danaher Corporation operates across the biotechnology, life sciences, and diagnostics sectors, delivering integrated solutions that enable the development and manufacture of therapeutic products globally. The company designs and manufactures specialized equipment, consumables, and services that address complex challenges in drug development, laboratory analysis, and clinical diagnostics. Within biotechnology, Danaher provides comprehensive bioprocess technologies and manufacturing support systems that streamline the creation of therapeutics. This includes cell culture media development, chromatography resins, filtration technologies, and single-use hardware alongside design and installation services for complete manufacturing suites. The company also offers laboratory-scale protein purification tools, analytical instruments, and healthcare filtration solutions that serve manufacturers and research institutions. The life sciences division encompasses advanced analytical instrumentation including mass spectrometers, flow cytometry systems, genomics platforms, and microscopy solutions. Danaher supplies critical consumables such as antibodies, reagents, and protein products, along with industrial filtration systems and genomic medicine offerings including custom nucleic acid products and plasmid DNA. These capabilities operate under several established brands that serve research and industrial applications.
Company Leadership
HC
NORC at the University of Chicago, established in 1941, is an independent research organization headquartered in downtown Chicago with additional offices on The University of Chicago's campus and in Washington, D.C. and Bethesda, Maryland.
Company Leadership
AD
MA
GL
NEFCO, headquartered in Rochester, New Hampshire, and established in 1993, is a fire investigation company. Their services include fire scene and explosion investigation, scene inspection, litigation support, and evidence storage.
Company Leadership DE
Aragen Life Sciences is a company that specializes in research and development operations for pharma, biotech, agrochemical, and animal health companies among other industries. They are based in Hyderabad, India.
Company Leadership MK
PN
Frequently Asked Questions Regarding Charles River Top Executives and Leadership Team
